1.
Borrás-Blasco J, Valcuende-Rosique A, Rosique-Robles D, Casterá E. Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up. J. Pharm. Nutr. Sci. [Internet]. 2022 Dec. 13 [cited 2024 Oct. 6];12:74-9. Available from: http://set-publisher.com/index.php/jpans/article/view/2440